DaVita (BSP:DVAI34) Other Long-Term Liabilities : R$897 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is DaVita Other Long-Term Liabilities?

DaVita's other long-term liabilities for the quarter that ended in Dec. 2023 was R$897 Mil.

DaVita's quarterly other long-term liabilities increased from Jun. 2023 (R$889 Mil) to Sep. 2023 (R$913 Mil) but then declined from Sep. 2023 (R$913 Mil) to Dec. 2023 (R$897 Mil).

DaVita's annual other long-term liabilities declined from Dec. 2021 (R$674 Mil) to Dec. 2022 (R$552 Mil) but then increased from Dec. 2022 (R$552 Mil) to Dec. 2023 (R$897 Mil).

DaVita Other Long-Term Liabilities Historical Data

The historical data trend for DaVita's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Other Long-Term Liabilities Chart

DaVita Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

DaVita Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

DaVita Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

DaVita Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of DaVita's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

DaVita (BSP:DVAI34) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (BSP:DVAI34) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

DVA:USA TRL:Germany

Address

2000 16th Street, Denver, CO, USA, 80202

Website

https://www.davita.com

DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

DaVita (BSP:DVAI34) Headlines

No Headlines